Fibrinogen for liver transplant patients
This trial tests whether giving fibrinogen, a protein that helps blood clot, reduces bleeding during liver transplant surgery. It may help patients with certain liver conditions who are at higher risk of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are scheduled to receive a liver from a deceased donor
- You have at least one of these conditions: low fibrinogen levels, alcoholic cirrhosis, NASH (fatty liver disease), or hepatitis C
- You do not have a living donor transplant
- You do not have a blood clotting disorder
- You are not allergic to plasma-based products
- You do not have liver cancer or primary biliary fibrosis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational treatment called INTERCEPT Fibrinogen Complex (IFC) for people with severe bleeding after a traumatic injury. The treatment helps restore a key blood-clotting protein to try to stop the bleeding and improve survival.
This trial tests whether giving a personalized dose of fibrinogen, a protein that helps blood clot, after heart surgery reduces bleeding and the need for blood transfusions. It aims to improve recovery for patients who need fibrinogen after being on a heart-lung machine.
This study compares two blood-clotting medicines used during liver transplant surgery. The goal is to see which one works better to control bleeding and keep you safe during the operation.
This study takes a small liver tissue sample (a liver biopsy) in men who previously received haemophilia gene therapy. The goal is to learn more about how the gene therapy works and how safe it is for the liver.
This study looks at two blood markers (AFP and PIVKA-II) in people getting a liver transplant for liver cancer. It aims to see if these markers can predict how well patients do after the transplant, which may help guide future treatment decisions.
This trial studies how doctors manage bleeding before, during, and after liver transplant surgery. The goal is to improve safety and outcomes for people receiving a new liver.
Hear when a new Liver Transplant Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.